Publication in Nature Immunology outlining the contribution of B cells to anticancer immunosurveillance highlights Alchemab's capabilities and potential to develop new cancer therapies

Source :: PR Newswire. May 14, 2024
Publication Year :: 2024
Abstract: CAMBRIDGE, England, May 14, 2024 /PRNewswire/ -- Alchemab Therapeutics (Alchemab), an antibody discovery company identifying naturally occurring antibodies from individuals resilient to disease, today announces the publication of a peer [...]

Subjects :: Antineoplastic agents -- Health aspects
Biological products -- Health aspects
Viral antibodies -- Health aspects
B cells -- Health aspects
Cancer -- Health aspects
Disease susceptibility -- Health aspects
Antibodies -- Health aspects
Antimitotic agents -- Health aspects
Business
News, opinion and commentary

Tools